MEDIHA AHMAD
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology VICTORIA, TX NPI 1124447255
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology TX GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$5,165.88
- Category: General Payments
- Program years: PY2018–2024
- Record count: 251
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,510.58 across 61 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,510.58 | 61 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $190.27 | 5 |
| Incyte Corporation | $174.39 | 4 |
| Merck Sharp & Dohme Corporation | $111.04 | 4 |
| Janssen Biotech, Inc. | $105.37 | 4 |
| Astellas Pharma US Inc | $92.56 | 6 |
| PharmaEssentia USA Corporation | $77.76 | 3 |
| Acerta Pharma LLC | $77.45 | 4 |
| Lilly USA, LLC | $77.24 | 3 |
| AVEO Pharmaceuticals, Inc. | $74.15 | 3 |
| Daiichi Sankyo Inc. | $69.30 | 3 |
| EMD Serono, Inc. | $64.57 | 3 |
| TAIHO ONCOLOGY, INC. | $56.24 | 2 |
| Medtronic, Inc. | $52.32 | 1 |
| EISAI INC. | $34.75 | 2 |
| SOBI, INC | $34.14 | 2 |
| E.R. Squibb & Sons, L.L.C. | $29.83 | 2 |
| Sumitomo Pharma America, Inc. | $22.50 | 1 |
| Coherus Biosciences Inc. | $22.15 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.88 | 1 |
| ARRAY BIOPHARMA INC | $20.67 | 1 |
| PFIZER INC. | $20.45 | 1 |
| TerSera Therapeutics LLC | $19.49 | 1 |
| Karyopharm Therapeutics Inc. | $17.83 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.70 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $14.32 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.21 | 1 |
By program year
Records — PY2024 (61)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.